{"id":"mer","rwe":[],"_fda":{"id":"5f798b21-eaf7-4952-accd-19f33193bde1","set_id":"56b13bcb-150a-473a-b37a-60bdd2f65aa7","openfda":{"unii":["5K1UO2888Y","1MBW07J51Q","ZW3Z11D0JV","411VRN1TV4","T4423S18FM"],"route":["ORAL"],"spl_id":["5f798b21-eaf7-4952-accd-19f33193bde1"],"brand_name":["Mer Detox 6019"],"spl_set_id":["56b13bcb-150a-473a-b37a-60bdd2f65aa7"],"package_ndc":["63083-6019-2"],"product_ndc":["63083-6019"],"generic_name":["MER DETOX"],"product_type":["HUMAN OTC DRUG"],"substance_name":["BAPTISIA TINCTORIA WHOLE","CALCIUM SULFIDE","GOLDENSEAL","NITRIC ACID","POTASSIUM DICHROMATE"],"manufacturer_name":["Professional Complementary Health Formulas"],"is_original_packager":[true]},"purpose":["*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."],"version":"2","warnings":["WARNINGS Consult a doctor if condition worsens or symptoms persist. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use."],"questions":["QUESTIONS Professional Formulas PO Box 2034 Lake Oswego, OR 97035"],"effective_time":"20260108","active_ingredient":["ACTIVE INGREDIENTS Baptisia tinctoria 3X Hydrastis canadensis 5X Kali bichromicum 6X Nitricum acidum 6X Hepar sulphuris calcareum 8X"],"inactive_ingredient":["INACTIVE INGREDIENTS 20% ethanol, purified water."],"indications_and_usage":["INDICATIONS For the temporary relief of exhaustion or weakness, muscle soreness, minor joint pain or stiffness, headache, dizziness, dry, itchy, or cracked skin, constipation, or diarrhea due to sensitivity to or exposure to amalgam fillings or related compounds.*"],"other_safety_information":["OTHER INFORMATION Tamper resistant. If seal is broken, do not use. After opening, close container tightly and store at room temperature away from heat."],"dosage_and_administration":["DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age."],"spl_product_data_elements":["Mer Detox 6019 Mer Detox BAPTISIA TINCTORIA WHOLE BAPTISIA TINCTORIA WHOLE GOLDENSEAL GOLDENSEAL POTASSIUM DICHROMATE DICHROMATE ION NITRIC ACID NITRIC ACID CALCIUM SULFIDE CALCIUM SULFIDE ALCOHOL WATER"],"pregnancy_or_breast_feeding":["If pregnant or breastfeeding, ask a healthcare professional before use."],"keep_out_of_reach_of_children":["Keep out of the reach of children."],"package_label_principal_display_panel":["LABEL Est 1985 Professional Formulas Complementary Health Mer Detox Homeopathic Remedy 2 FL. OZ. (59 mL) Label image"]},"_tga":{"status":"Registered","regulator":"TGA","artgNumber":""},"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DYSURIA","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"INFLUENZA","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"MICTURITION URGENCY","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"NASAL CONGESTION","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"OSTEOPOROSIS","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"PROSTATE TENDERNESS","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"RENAL DISORDER","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"RENAL PAIN","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"TESTICULAR SWELLING","source":"FDA FAERS","actionTaken":"1 reports"}],"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ibuprofen","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Naproxen","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Celecoxib","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentoxifylline","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticlopidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cilostazol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Edoxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bemiparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadroparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticagrelor","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prasugrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cangrelor","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Esomeprazole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Lansoprazole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Omeprazole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pantoprazole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rabeprazole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Famotidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nizatidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ranitidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Cimetidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Furosemide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bumetanide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Torsemide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Indapamide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Hydrochlorothiazide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Chlorthalidone","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Metolazone","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Triamterene","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Amiloride","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Spironolactone","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eplerenone","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fenoldopam","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enalapril","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Lisinopril","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Captopril","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Quinapril","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ramipril","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Trandolapril","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Perindopril","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bisoprolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Metoprolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pindolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Propranolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Sotalol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Atenolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Labetalol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Carvedilol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bucindolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nebivolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Esmolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Carteolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Acebutolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Betaxolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Celiprolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Penbutolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prenalterol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Oxyprenolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alprenolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pindolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Sotalol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Propranolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Metoprolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bisoprolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Labetalol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Carvedilol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nebivolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Esmolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Carteolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Acebutolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Betaxolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Celiprolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Penbutolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prenalterol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Oxyprenolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alprenolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pindolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Sotalol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Propranolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Metoprolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bisoprolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Labetalol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Carvedilol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nebivolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Esmolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Carteolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Acebutolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Betaxolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Celiprolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Penbutolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Prenalterol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Oxyprenolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alprenolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pindolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Sotalol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Propranolol","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Nadolol","action":"Monitor","effect":"Increased risk of bleeding"}],"commonSideEffects":[],"contraindications":["Allergies to Ingredients: People who are allergic to any of the following should not use meropenem. - Meropenem - Merrem - Any of the ingredients in the specific product dispensed","Allergies to Certain Antibiotics: You should not use meropenem if you have an allergy to certain types of antibiotics, including penicillins, cephalosporins, carbapenems, or monobactams.","Seizure medicine: If you have a history of seizures, it is important that you take any seizure medicine as prescribed while using meropenem."],"specialPopulations":{"Pregnancy":"Women who have significant renal insufficiency before pregnancy usually cannot maintain a pregnancy to term. In pregnant women with renal insufficiency, measure BP and weight every 2 weeks, and measure BUN and creatinine levels plus creatinine clearance often, as indicated by severity and progression of disease. After kidney transplantation, full-term, uncomplicated pregnancy is often possible if women have all of the following: A transplanted kidney that has been in place for > 2 years, Normal renal function, No episodes of rejection. Advances in dialysis treatment have increased life expectancy for patients with end-stage renal disease, improved pregnancy outcomes, and increased fertility. The survival rate for fetuses of pregnant women receiving hemodialysis has improved from 23% (in about 1980) to almost 90% currently. The reason is probably the substantial increase in hemodialysis dose used during pregnancy; now, high-flux, high-efficiency hemodialysis is used.","Geriatric use":"No information available","Paediatric use":"No information available","Renal impairment":"Renal disorders often do not worsen during pregnancy; noninfectious renal disorders are usually exacerbated only when uncontrolled hypertension coexists. However, significant renal insufficiency (serum creatinine > 3 mg/dL [> 270 micromol/L] or blood urea nitrogen [BUN] 270 micromol/L] or blood urea nitrogen [BUN]> 30 mg/dL [> 10.5 mmol urea/L]) before pregnancy usually prevents women from maintaining a pregnancy to term. Maternal renal insufficiency may cause Fetal growth restriction, Stillbirth.","Hepatic impairment":"No information available"}},"trials":[],"_whoEML":{"listed":true,"source":"WHO EML"},"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_fixedAt":"2026-03-30T11:27:07.472906","_recalls":[{"date":"20130731","reason":"Subpotent Drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeled","classification":"Class III"},{"date":"20130731","reason":"Subpotent Drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeled","classification":"Class III"},{"date":"20130731","reason":"Subpotent drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeled","classification":"Class III"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=mer","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:36:10.019747+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-19T23:36:47.423382+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:36:15.954706+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:36:10.091526+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=mer","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:36:16.319954+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:36:08.606143+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:36:42.749272+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T23:36:08.606176+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-19T23:36:17.829141+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Gonadotropin-releasing hormone receptor antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:36:17.428033+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL262747/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:36:17.079291+00:00"}},"allNames":"mer detox 6019","offLabel":[],"timeline":[],"_dailymed":{"setId":"dbe965b3-e81e-4328-bc41-43e875e12a05","title":"DENTOX (BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, PHYTOLACCA DECANDRA, LYMPH NODE(SUIS), MEDULLA OSSIS SUIS, THYMUS (SUIS), THYROIDINUM (SUIS), CALCAREA FLUORICA, NATRUM FLUORATUM, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, EUGENOL, FORMALINUM, LIDOCAINE, MERCURIUS SOLUBILIS, MOLYBDENUM, NICCOLUM METALLICUM, PALLADIUM METALLICUM, STANNUM METALLICUM, TITANIUM METALLICUM, ZINCUM METALLICUM) LIQUID [BIOACTIVE NUTRITIONAL, INC.]","labeler":""},"aiSummary":"Mer Detox 6019, marketed by Pfizer, is positioned in the niche market addressing exhaustion or weakness. A key strength lies in its unique mechanism of action, which remains unspecified, setting it apart from competitors. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics.","brandName":"Mer Detox 6019","ecosystem":[],"isGeneric":true,"mechanism":{"target":"Unknown","novelty":"Unknown","modality":"Unknown","drugClass":"Unknown","explanation":"","oneSentence":"","technicalDetail":"The mechanism of action for MER is not specified, making it challenging for healthcare professionals to understand its effects on the body. Without this information, it is difficult to determine the drug's potential interactions with other medications or its effects on specific patient populations."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"yoyGrowth":"7%","annualCostUS":"$80,000/yr","genericStatus":"Generic — off-patent","currentRevenue":"","peakSalesEstimate":""},"references":[{"id":1,"url":"https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mer","fields":["mechanism","safety","indications","administration"],"source":"FDA Drug Label (DailyMed)"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=mer","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=mer","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":5,"url":"https://open.fda.gov/apis/drug/event/","fields":["safetySignals"],"source":"FDA FAERS"},{"id":6,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":7,"url":"https://www.whocc.no/atc_ddd_index/","fields":["classification"],"source":"WHO ATC/DDD Index"},{"id":8,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-19T23:36:47.423497+00:00","fieldsConflicting":2,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Tom Ford White Suede Hand Cream","company":"Tom Ford","advantage":"Most similar ingredients to La Mer's The Hand Treatment, with a 68% ingredient match"},{"name":"Aerin Body Cream","company":"Aerin","advantage":"Contains hyaluronic acid and peptides, with 40 ingredients in common with La Mer The Body Crème"},{"name":"Clinique All About Clean Foaming Facial Soap","company":"Clinique","advantage":"Does not contain parabens, similar to La Mer products"},{"name":"Estée Lauder Perfectly Clean Multi-Action Foam Cleanser/Purifying Mask","company":"Estée Lauder","advantage":"Similar to La Mer products, but with a different function"},{"name":"Nivea Crème","company":"Nivea","advantage":"Similar to La Mer products, but with a different function"},{"name":"Darphin Ideal Resource Restorative Bright Eye Cream","company":"Darphin","advantage":"Similar to La Mer products, but with a different function"},{"name":"GLAMGLOW BRIGHTEYES Illuminating Anti-Fatigue Eye Cream","company":"GLAMGLOW","advantage":"Similar to La Mer products, but with a different function"},{"name":"Estée Lauder Perfectionist Pro Rapid Firm + Lift Serum","company":"Estée Lauder","advantage":"Similar to La Mer products, but with a different function"},{"name":"Estée Lauder Advanced Night Repair Intense Reset Concentrate","company":"Estée Lauder","advantage":"Similar to La Mer products, but with a different function"},{"name":"Jo Malone London Restore Body Oil","company":"Jo Malone London","advantage":"Similar to La Mer products, but with a different function"},{"name":"Pat McGrath Labs Sublime Perfection Setting Powder","company":"Pat McGrath Labs","advantage":"Similar to La Mer products, but with a different function"},{"name":"Merle Norman Foaming Cleanser Normal/Oily","company":"Merle Norman","advantage":"Similar to La Mer products, but with a different function"},{"name":"Clinique All About Eyes Rich Eye Cream","company":"Clinique","advantage":"Similar to La Mer products, but with a different function"},{"name":"Too Faced Hangover Pillow Balm Nourishing Lip Treatment","company":"Too Faced","advantage":"Similar to La Mer products, but with a different function"}],"dataSources":[{"url":"https://tavily.com","name":"Tavily AI Search","fields":["latestUpdates"],"retrievedDate":"2026-04-07"},{"url":"https://jina.ai/reader","name":"Jina Reader","fields":["commercialAnalysis"],"retrievedDate":"2026-04-07"},{"url":"https://groq.com","name":"Groq (Llama 3.1 8B)","fields":["commercialAnalysis"],"retrievedDate":"2026-04-07"}],"genericName":"mer","indications":{"approved":[{"id":"mer-exhaustion-or-weakness","name":"Exhaustion or Weakness","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing exhaustion or weakness","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing exhaustion or weakness","diagnosticRequired":null,"brandNameForIndication":"Mer Detox 6019"},{"id":"mer-muscle-soreness","name":"Muscle Soreness","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing muscle soreness","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing muscle soreness","diagnosticRequired":null,"brandNameForIndication":"Mer Detox 6019"},{"id":"mer-minor-joint-pain-or-stiffness","name":"Minor Joint Pain or Stiffness","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing minor joint pain or stiffness","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing minor joint pain or stiffness","diagnosticRequired":null,"brandNameForIndication":"Mer Detox 6019"},{"id":"mer-headache","name":"Headache","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing headache","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing headache","diagnosticRequired":null,"brandNameForIndication":"Mer Detox 6019"},{"id":"mer-dizziness","name":"Dizziness","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing dizziness","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing dizziness","diagnosticRequired":null,"brandNameForIndication":"Mer Detox 6019"},{"id":"mer-dry,-itchy,-or-cracked-skin","name":"Dry, Itchy, or Cracked Skin","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing dry, itchy, or cracked skin","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing dry, itchy, or cracked skin","diagnosticRequired":null,"brandNameForIndication":"Mer Detox 6019"},{"id":"mer-constipation","name":"Constipation","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing constipation","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing constipation","diagnosticRequired":null,"brandNameForIndication":"Mer Detox 6019"},{"id":"mer-diarrhea","name":"Diarrhea","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing diarrhea due to sensitivity to or exposure to amalgam fillings or related compounds","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing diarrhea due to sensitivity to or exposure to amalgam fillings or related compounds","diagnosticRequired":null,"brandNameForIndication":"Mer Detox 6019"}],"offLabel":[],"pipeline":[]},"_drugWebsite":{"url":"https://www.mer.com","content":"Skip to content\nDownload Brochure\n  \nSign In\nConference Schedule Topics Accreditation Contact Us FAQ\n   \n\n   \n\n   \n\n   \n   \nVIEW ALL CONFERENCES →\n   \n   \n   \n   \n   \n   \n   \nVIEW ALL CONFERENCES →\n   \n   \n   \n   \n   \n   \n   \nVIEW ALL CONFERENCES →\n   \n   \n   \n   \n   \n   \n   \nVIEW ALL CONFERENCES →\nFilter by Destination\nFilter by Month\nFilter by Topic\n Reset Filters\nMarch 2026\nNevada, Las Vegas\nDistrict of Columbia, Washington D.C.\nItaly, Lake Como\nApril 2026\nMay 2026\nJune 2026\nJuly 2026\nAugust 2026\nSeptember 2026\nOctober 2026\nNovember 2026\nDecember 2026\nJanuary 2027\nFebruary 2027\nMarch 2027\nApril 2027\nMay 2027\nInternal Medicine for Primary Care: Gastro/Neuro/Psych\nMar 27-29, 2026\nLas Vegas, Nevada\nInternal Medicine for Primary Care: Endo/Neuro/Vasc\nMar 27-29, 2026\nWashington DC\nInternal Medicine for Primary Care: Cardio/Endo/ID/Rheum\nMar 30 - Apr 02, 2026\nLake Como, Italy\nDermatology for Primary Care\nApr 03-05, 2026\nNapa, California\nInternal Medicine for Primary Care: Gastro/Pain/Psych/Vasc\nApr 09-12, 2026\nWalt Disney World® Resort, Florida\nPediatric & Adolescent Medicine for Primary Care: ENT/Gastro/Gyn/Sports Med\nApr 09-12, 2026\nHilton Head Island, South Carolina\nGeriatric Medicine for Primary Care: Cardio/Derm/Geri\nApr 10-12, 2026\nLas Vegas, NV\nInternal Medicine for Primary Care: Cardio/Geri/ID/Neck & Spine\nApr 12-16, 2026\nWaimea, Hawaii\nCardiology & Pulmonology for Primary Care\nApr 17-19, 2026\nTucson, Arizona\nMen's & Women's Health for Primary Care: Gyn/Men's Uro/Psych\nApr 24-26, 2026\nWalt Disney World® Resort, Florida\nGeriatric Medicine for Primary Care: Geri/Ophth/Rheum\nApr 24-26, 2026\nNew Orleans, Louisiana\nNeurology & Psychiatry for Primary Care\nApr 24-26, 2026\nCharleston, South Carolina\nInternal Medicine for Primary Care: Derm/Geri/Men's Uro/Pulm\nApr 27-30, 2026\nBarcelona, Spain\nInternal Medicine for Primary Care: Endo/Gastro Nutrition/Obesity\nMay 05-08, 2026\nBuenos Aires, Argentina\nInternal Medicine for Primary Care: Gastro/Neuro/Pain/Psych\nMay 14-17, 202"},"_fixedFields":["generics(12)","patents(0)"],"_mhraChecked":true,"labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[],"trialDetails":[{"nctId":"NCT00843882","phase":"PHASE3","title":"Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-01-29","conditions":"Anemia, Chronic Myelomonocytic Leukemia, De Novo Myelodysplastic Syndrome","enrollment":247},{"nctId":"NCT06309485","phase":"PHASE2","title":"Phase 2 Study of WGI-0301 for Advanced HCC","status":"RECRUITING","sponsor":"Zhejiang Haichang Biotech Co., Ltd.","startDate":"2024-07-31","conditions":"Advanced Hepatocellular Carcinoma (HCC)","enrollment":60},{"nctId":"NCT06183944","phase":"","title":"Data Clustering Study With Artificial Intelligence and Phenotyping of Patients With Acute Pulmonary Embolism","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2023-12-11","conditions":"Pulmonary Embolism","enrollment":2500},{"nctId":"NCT07355582","phase":"","title":"Injury Incidence, Severity and Burden in Elite Youth Rugby Players","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2025-12-18","conditions":"Rugby-related Injuries","enrollment":400},{"nctId":"NCT04692181","phase":"PHASE1, PHASE2","title":"SYN-004 Safety and Tolerability in Allo-HCT Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Theriva Biologics, Inc.","startDate":"2021-02-15","conditions":"Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant, Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics","enrollment":36},{"nctId":"NCT06581874","phase":"NA","title":"Evaluation of a Collaborative Mental Health Care System","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2025-03-03","conditions":"Psychiatric Adults Patients","enrollment":418},{"nctId":"NCT05438420","phase":"PHASE1, PHASE2","title":"Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qurient Co., Ltd.","startDate":"2023-01-12","conditions":"Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer","enrollment":120},{"nctId":"NCT06814717","phase":"PHASE2","title":"A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns","status":"RECRUITING","sponsor":"Neomatrix Therapeutics, Inc.","startDate":"2025-05-12","conditions":"Thermal Burns","enrollment":6},{"nctId":"NCT04963283","phase":"PHASE2","title":"Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2021-06-23","conditions":"Colorectal Adenocarcinoma, Colon Cancer, Colon Adenocarcinoma","enrollment":48},{"nctId":"NCT04648254","phase":"PHASE1","title":"Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor","status":"COMPLETED","sponsor":"Qurient Co., Ltd.","startDate":"2020-11-18","conditions":"Solid Tumor, Advanced Cancer, Metastatic Cancer","enrollment":51},{"nctId":"NCT06177197","phase":"NA","title":"Bronchiolitis Clearance Airways With Seaserum","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-01-10","conditions":"Bronchiolitis Acute","enrollment":458},{"nctId":"NCT04884412","phase":"NA","title":"Deep Brain Stimulation for Parkinson's Disease: Probabilistic STN Targeting Under General Anaesthesia Without Micro-electrode Recordings vs Current Targeting Procedure","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2021-11-10","conditions":"Parkinson Disease","enrollment":128},{"nctId":"NCT04116541","phase":"PHASE2","title":"A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.","status":"RECRUITING","sponsor":"Centre Leon Berard","startDate":"2020-01-28","conditions":"Malignant Solid Tumor","enrollment":455},{"nctId":"NCT07056361","phase":"NA","title":"Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control","status":"RECRUITING","sponsor":"Jorge Gonzalez-Martinez","startDate":"2022-12-16","conditions":"Movement Disorders (Incl Parkinsonism), Stroke, Traumatic Brain Injury","enrollment":60},{"nctId":"NCT06712810","phase":"PHASE1","title":"Q702 for the Treatment of Patients With Hematologic Malignancies","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-27","conditions":"Hematopoietic and Lymphatic System Neoplasm, Histiocytic Sarcoma, Malignant Histiocytosis","enrollment":46},{"nctId":"NCT03522142","phase":"PHASE1","title":"A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies","status":"TERMINATED","sponsor":"Incyte Corporation","startDate":"2018-08-27","conditions":"Advanced Solid Tumors","enrollment":83},{"nctId":"NCT06669403","phase":"PHASE1","title":"OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis","status":"NOT_YET_RECRUITING","sponsor":"Op-T LLC","startDate":"2025-12","conditions":"Sepsis, Community Acquired Pneumonia (CAP)","enrollment":26},{"nctId":"NCT04589403","phase":"PHASE1","title":"1a/1b Study of OPT101 First in Human Study Assessing Safety and Tolerability of 15-mer Peptide.","status":"COMPLETED","sponsor":"Op-T LLC","startDate":"2021-02-18","conditions":"Healthy","enrollment":14},{"nctId":"NCT04458259","phase":"PHASE1","title":"Study of PF-07265807 in Participants With Metastatic Solid Tumors.","status":"TERMINATED","sponsor":"Pfizer","startDate":"2020-09-24","conditions":"Neoplasm Metastasis","enrollment":88},{"nctId":"NCT07136454","phase":"","title":"Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome","status":"AVAILABLE","sponsor":"Oak Hill Bio Ltd","startDate":"","conditions":"Angelman Syndrome","enrollment":""},{"nctId":"NCT06799650","phase":"PHASE2","title":"Clinical Trial of Gammora® Plus Antiretroviral Treatment for HIV","status":"RECRUITING","sponsor":"Federal University of São Paulo","startDate":"2025-01-01","conditions":"HIV Seropositivity","enrollment":40},{"nctId":"NCT06658132","phase":"NA","title":"A General Anesthesia Regimen for DBS Surgery in Patients With PD","status":"COMPLETED","sponsor":"RenJi Hospital","startDate":"2024-10-29","conditions":"Parkinson's Disease (PD)","enrollment":20},{"nctId":"NCT04762199","phase":"PHASE1","title":"MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"Emory University","startDate":"2021-02-24","conditions":"Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8","enrollment":69},{"nctId":"NCT01550523","phase":"PHASE1","title":"Pilot Immunotherapy Trial for Recurrent Malignant Gliomas","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2012-02-09","conditions":"Malignant Glioma of Brain","enrollment":13},{"nctId":"NCT03329092","phase":"PHASE3","title":"A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-04-05","conditions":"Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia, Ventilator Associated Pneumonia","enrollment":422},{"nctId":"NCT05200143","phase":"PHASE2","title":"Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma","status":"TERMINATED","sponsor":"Providence Health & Services","startDate":"2022-06-08","conditions":"Refractory Cutaneous Melanoma","enrollment":4},{"nctId":"NCT06543563","phase":"NA","title":"Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's Disease","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-08-09","conditions":"PD - Parkinson's Disease, Deep Brain Stimulation, Esketamine","enrollment":102},{"nctId":"NCT05550714","phase":"NA","title":"Choice of Anesthesia in Microelectrode Recording Guided Deep Brain Stimulation for Parkinson's Disease","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2022-10-15","conditions":"PD - Parkinson's Disease, Dexmedetomidine, Desflurane","enrollment":188},{"nctId":"NCT03176277","phase":"PHASE1, PHASE2","title":"A Study of ONO-7475 in Patients With Acute Leukemias","status":"TERMINATED","sponsor":"Ono Pharmaceutical Co. Ltd","startDate":"2017-06-26","conditions":"Acute Leukemia, Myelodysplastic Syndromes","enrollment":42},{"nctId":"NCT06293677","phase":"PHASE4","title":"Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2024-03-01","conditions":"Febrile Neutropenia","enrollment":30},{"nctId":"NCT03283150","phase":"PHASE4","title":"Deep Brain Stimulation (DBS) Sedation","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2017-12-01","conditions":"Brain, Sedation","enrollment":20},{"nctId":"NCT04116242","phase":"","title":"MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2015-08-27","conditions":"Liver Disease, Cirrhosis of the Liver, Acute-On-Chronic Liver Failure","enrollment":277},{"nctId":"NCT02320266","phase":"","title":"Sensory Gating Measured With Microelectrode Recording (MER) During Deep Brain Stimulation (DBS) Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"University of Colorado, Denver","startDate":"2014-12","conditions":"Parkinson's Disease, Essential Tremor, Dystonia","enrollment":150},{"nctId":"NCT05428943","phase":"PHASE1","title":"OPT101 in Type 1 Diabetes Patients","status":"COMPLETED","sponsor":"Op-T LLC","startDate":"2022-09-27","conditions":"Diabetes Mellitus, Type 1","enrollment":22},{"nctId":"NCT05649865","phase":"","title":"Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)","status":"RECRUITING","sponsor":"Region Skane","startDate":"2023-05-15","conditions":"Oropharynx Squamous Cell Carcinoma","enrollment":150},{"nctId":"NCT01191775","phase":"PHASE1","title":"A Study of PNT2258 in Patients With Advanced Solid Tumors","status":"COMPLETED","sponsor":"Sierra Oncology LLC - a GSK company","startDate":"2010-08","conditions":"Cancer, Lymphoma, Prostate Cancer","enrollment":22},{"nctId":"NCT05453331","phase":"","title":"Asleep MRI-guided Versus Awake Microelectrode Recording Guided Deep Brain Stimulation in Parkinson's Disease: A Comparative Effectiveness Trial","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2022-10","conditions":"Parkinson Disease","enrollment":158},{"nctId":"NCT05376761","phase":"PHASE4","title":"EC50 of Dexmedetomidine in Deep Brain Stimulation Implantation of Patients With Parkinson's Disease","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2022-05-31","conditions":"PD - Parkinson's Disease","enrollment":40},{"nctId":"NCT05204264","phase":"NA","title":"Mindfulness-based Emotional Regulation Versus ACT in Anxiety","status":"UNKNOWN","sponsor":"Hospital Universitario La Paz","startDate":"2019-02-18","conditions":"Anxiety","enrollment":128},{"nctId":"NCT04322630","phase":"","title":"Mer-TK in Human Cardiac Cells","status":"COMPLETED","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2019-05-10","conditions":"Myocardial Inflammation, Myocardial Infarction","enrollment":50},{"nctId":"NCT04801017","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects","status":"UNKNOWN","sponsor":"Oncotelic Inc.","startDate":"2021-04","conditions":"COVID-19","enrollment":18},{"nctId":"NCT01883973","phase":"","title":"MER Versus MRI Guidance DBS in Parkinson's Disease","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2011-05","conditions":"Idiopathic Parkinson's Disease (PD)","enrollment":7},{"nctId":"NCT04513405","phase":"NA","title":"Estrogens Levels and Receptors Status and Skin Tears","status":"UNKNOWN","sponsor":"University of Catanzaro","startDate":"2020-09-01","conditions":"Skin Tear, Estrogen Deficiency","enrollment":1200},{"nctId":"NCT04253990","phase":"NA","title":"Efficacy and Safety of Precut-EMR for Resecting of Colonic Polyp","status":"WITHDRAWN","sponsor":"Asan Medical Center","startDate":"2016-05","conditions":"Colonic Polyps","enrollment":0},{"nctId":"NCT03928951","phase":"","title":"General Practitioner Reassessment of Urinary Infection Antibiotherapy Prescribed by Emergency Departments","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2019-06-14","conditions":"Urinary Tract Infections","enrollment":50},{"nctId":"NCT03960398","phase":"","title":"Incidence of Iatrogenic Diseases on Hospital's Emergency Consultations","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2019-06-28","conditions":"Iatrogenic Disease","enrollment":2500},{"nctId":"NCT03133429","phase":"NA","title":"Clinical Study to Evaluate the Safety and Effectiveness of MER® Stents in Carotid Revascularisation.","status":"COMPLETED","sponsor":"Balton Sp.zo.o.","startDate":"2016-10","conditions":"Carotid Artery Stenosis","enrollment":100},{"nctId":"NCT03454243","phase":"EARLY_PHASE1","title":"Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors","status":"TERMINATED","sponsor":"Hoffmann-La Roche","startDate":"2018-02-15","conditions":"Advanced or Metastatic Solid Tumors","enrollment":1},{"nctId":"NCT01721460","phase":"PHASE4","title":"Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2012-11","conditions":"Parkinson's Disease, Deep Brain Stimulation Surgery","enrollment":6},{"nctId":"NCT03363724","phase":"","title":"Validation of HaGuide Software Module Accuracy in Mapping STN Boundaries in Parkinson's Disease Patients Who Underwent DBS Procedure","status":"COMPLETED","sponsor":"Alpha Omega Engineering Ltd.","startDate":"2016-12","conditions":"Parkinson Disease, Deep Brain Stimulation","enrollment":103},{"nctId":"NCT02723981","phase":"PHASE4","title":"COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials","status":"WITHDRAWN","sponsor":"IHF GmbH - Institut für Herzinfarktforschung","startDate":"2016-04","conditions":"Stable Angina, Unstable Angina, STEMI","enrollment":0},{"nctId":"NCT02661074","phase":"","title":"Anisakis Blastocystis Cryptosporidium Fish Prevalence","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2014-11","conditions":"Anisakis, Allergy, Occupational Exposure","enrollment":486},{"nctId":"NCT02605109","phase":"","title":"Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV)","status":"COMPLETED","sponsor":"Konkuk University Medical Center","startDate":"2015-06","conditions":"Viral Infection","enrollment":200},{"nctId":"NCT02855333","phase":"","title":"Feasibility, Safety and QoL After Merendino Procedure","status":"COMPLETED","sponsor":"Kantonsspital Liestal","startDate":"2014-05","conditions":"Benign or Early Malignant Lesion of the Distal Esophagus or Gastro-esophageal Junction Requiring Surgical Resection","enrollment":26},{"nctId":"NCT01139333","phase":"","title":"Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2009-09","conditions":"Leukemia","enrollment":52},{"nctId":"NCT02572336","phase":"PHASE2","title":"A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA","status":"UNKNOWN","sponsor":"D-Pharm Ltd.","startDate":"2015-10","conditions":"Ischemic Stroke","enrollment":40},{"nctId":"NCT02435459","phase":"NA","title":"The Effect of Different Lining Strategies on Amalgam Restorations","status":"UNKNOWN","sponsor":"University of Birmingham","startDate":"2012-04","conditions":"Post-operative Pain, Dental Caries","enrollment":640},{"nctId":"NCT01957774","phase":"PHASE2","title":"THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA","status":"COMPLETED","sponsor":"D-Pharm Ltd.","startDate":"2013-10","conditions":"Stroke, Acute","enrollment":30},{"nctId":"NCT01478867","phase":"","title":"Detection of Immunotoxic Gluten Peptides in Feces","status":"COMPLETED","sponsor":"University of Seville","startDate":"2011-04","conditions":"Celiac Disease","enrollment":53},{"nctId":"NCT00603187","phase":"PHASE1, PHASE2","title":"ACY-7 Oral Administration of Acyline","status":"COMPLETED","sponsor":"University of Washington","startDate":"2008-01","conditions":"Healthy","enrollment":4}],"_emaApprovals":[{"date":"","name":"MER","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[{"url":"https://www.merck.com/wp-content/uploads/sites/124/2026/02/4Q25-Merck-Earnings-Announcement.pdf","date":"2026-04-07","type":"news","title":"[PDF] News Release - Merck.com","source":"www.merck.com"},{"url":"https://www.grandviewresearch.com/industry-analysis/detox-product-market","date":"2026-04-07","type":"news","title":"Detox Products Market Size, Share & Growth Report, 2030","source":"www.grandviewresearch.com"},{"url":"https://www.drugdiscoverytrends.com/pharma-50-2026-the-top-spot-in-pharma-rarely-lasts-lilly-is-betting-it-can-change-that/","date":"2026-04-07","type":"news","title":"Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting ...","source":"www.drugdiscoverytrends.com"},{"url":"https://cdn.pfizer.com/pfizercom/product-pipeline/Q1_2025_Pipeline_Update_29APR2025.pdf?VersionId=7hjVCBiYrHhTyTEE1tgA5DD8Hp4qB0vo","date":"2026-04-07","type":"news","title":"[PDF] 5 - Pfizer Pipeline","source":"cdn.pfizer.com"},{"url":"https://cdn.pfizer.com/pfizercom/product-pipeline/Q4%202025%20Pipeline%20Update_vFinal3.pdf?VersionId=XSLcQ04JnYn3Py.PPsUP_5lAboV.fDPh","date":"2026-04-07","type":"news","title":"[PDF] Pfizer Pipeline","source":"cdn.pfizer.com"}],"manufacturing":[{"role":"Manufacturer","site":"Professional Complementary Health Formulas","location":"","operator":"Professional Complementary Health Formulas"}],"molecularData":{"oral":false,"chemblId":"CHEMBL262747","moleculeType":"Protein","molecularWeight":"1533.24"},"administration":{"route":"Oral"},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"unii":"5K1UO2888Y","splId":"5f798b21-eaf7-4952-accd-19f33193bde1","chemblId":"CHEMBL262747","pubchemSID":"821603"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[{"period":"?-present","_source":"FDA label","companyName":"Professional Complementary Health Formulas","relationship":"Originator"}],"publicationCount":18504,"therapeuticAreas":["Pain"],"_revenueScrapedAt":"2026-03-31 09:33:22.212689+00","atcClassification":{"atcCode":"D08AK04","atcName":"merbromin"},"biosimilarFilings":[],"commercialAnalysis":{"text":"Mer Detox 6019 (Mer) by Pfizer is a detox product with a broad range of indications, including temporary relief of exhaustion, muscle soreness, joint pain, headache, and dizziness. However, the exact mechanism of action is not specified on Wikipedia. As a result, we cannot accurately assess its market position or revenue trajectory.\n\nThe global detox products market is expected to grow at a CAGR of 7.5% from 2023 to 2030, driven by increasing consumer awareness of the importance of detoxification (Grand View Research, 2023). However, the market is highly competitive, with numerous players vying for market share. Pfizer's revenue from Mer Detox 6019 is not publicly disclosed, making it challenging to assess its market position.\n\nThe competitive landscape for Mer Detox 6019 is dominated by other detox products, such as those offered by Merck & Co. (Merck, 2025). Merck's WINREVAIR sales were $1.4 billion in 2025, indicating a significant presence in the detox market (Merck, 2025). Additionally, Lilly is betting on its pipeline to change the top spot in pharma, which may pose a threat to Pfizer's market position (Drug Discovery Trends, 2026).\n\nKey upcoming catalysts for Mer Detox 6019 include patent cliffs, label expansions, and pipeline competitors. However, without specific data on Mer Detox 6019's patent status or pipeline competitors, it is challenging to assess these risks. The market outlook for Mer Detox 6019 is uncertain, and further research is needed to accurately assess its market position and revenue trajectory.\n\nReferences:\n- Grand View Research (2023). Detox Products Market Size, Share & Growth Report, 2030.\n- Merck (2025). News Release - Merck.com.\n- Drug Discovery Trends (2026). Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.","model":"llama-3.1-8b (Groq)","sources":[{"url":"https://www.merck.com/wp-content/uploads/sites/124/2026/02/4Q25-Merck-Earnings-Announcement.pdf","date":"","title":"[PDF] News Release - Merck.com","source":"www.merck.com"},{"url":"https://www.grandviewresearch.com/industry-analysis/detox-product-market","date":"","title":"Detox Products Market Size, Share & Growth Report, 2030","source":"www.grandviewresearch.com"},{"url":"https://www.drugdiscoverytrends.com/pharma-50-2026-the-top-spot-in-pharma-rarely-lasts-lilly-is-betting-it-can-change-that/","date":"","title":"Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting ...","source":"www.drugdiscoverytrends.com"}],"disclaimer":"AI-generated analysis based on public sources. Verify with primary sources for investment decisions.","generatedDate":"2026-04-07"},"recentPublications":[{"date":"2026 Mar 28","pmid":"41903124","title":"Integrative computational analysis of Marburg virus protein mutations: structural and functional implications of Glycoprotein variants and natural inhibitor screening.","journal":"Journal of biomolecular structure & dynamics"},{"date":"2026 Mar 28","pmid":"41902742","title":"Fast Hashing of Spaced Seeds with DuoHash.","journal":"Journal of computational biology : a journal of computational molecular cell biology"},{"date":"2026 Feb 25","pmid":"41902188","title":"Alignment-Free Machine Learning Serotype Classification of the Dengue Virus.","journal":"Viruses"},{"date":"2026 Mar 28","pmid":"41896977","title":"RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia.","journal":"Journal of experimental & clinical cancer research : CR"},{"date":"2026 Mar 20","pmid":"41894894","title":"Benchmarking size-exclusion chromatography columns for the analysis of therapeutic peptides and model oligonucleotides.","journal":"Journal of chromatography. A"}],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"_investorTranscripts":{"url":"https://www.pfizer.com/investors/presentations","source":"Investor transcripts","mentions":["Merchandise"]},"companionDiagnostics":[],"genericManufacturers":12,"_genericFilersChecked":true,"genericManufacturerList":["Acs Dobfar","Acs Dobfar Spa","Amneal Pharms","Brooks Steriscience","Daewoong Pharm Co","Eugia Pharma","Gland","Hospira Inc","Hq Spclt Pharma","Qilu","Sandoz","Savior Lifetec Corp"],"phase":"marketed","status":"approved","companyName":"Pfizer","companyId":"pfizer","modality":"Unknown","firstApprovalDate":"","enrichmentLevel":3,"visitCount":9,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-19T23:36:47.423497+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}